ProShares UltraShort NASDAQ Biotechnology
2 hedge funds and large institutions have $333K invested in ProShares UltraShort NASDAQ Biotechnology in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$310K |
Top Sellers
| 1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$0 |
| 2 |
2
Jane Street
New York
|
$0 |
| 3 |
U
3
UBS
Zurich,
Switzerland
|
$23K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $310K | 12,159 | +5,146 | +73% |
|
|
U
2
UBS
Zurich,
Switzerland
| $23K | 888 | -98 | -10% |
|
|
CS
3
Credit Suisse
Zurich,
Switzerland
| – | – | -34,468 | Closed |
|
|
4
Jane Street
New York
| – | – | -5,659 | Closed |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | – | – | – |
|